Global Acute Myocardial Infarction Perspectives: Beyond Door-to-Balloon Interventions

Sameer Mehta1, Jennifer C Kostela2, Estefania Oliveros3

  • 1Miller School of Medicine, University of Miami, 1400 Northwest 12th Avenue, Miami, FL 33136, USA; Mercy Medical Center, 3663 South Miami Avenue, Miami, FL 33133, USA; Lumen Foundation, 55 Pinta Road, Miami, FL 33133, USA.

Insights

Achieving rapid STEMI treatment is crucial. A global strategy using a pharmacoinvasive approach, tailored to socioeconomic factors, is proposed for acute myocardial infarction care.

Area of Science:

  • Cardiology
  • Public Health
  • Health Economics

Background:

  • The primary goal of ST-elevation myocardial infarction (STEMI) intervention is to achieve a door-to-balloon time under 90 minutes.
  • Key challenges in North America and Europe include patient education and implementing legislative STEMI guidelines.
  • Globally, primary percutaneous coronary intervention faces hurdles like limited access and financial constraints for widespread STEMI care.

Purpose of the Study:

  • To address the global disparities in STEMI care.
  • To propose a feasible strategy for acute myocardial infarction management in diverse socioeconomic settings.
  • To introduce a pharmacoinvasive approach as an alternative to primary percutaneous coronary intervention.

Main Methods:

  • A four-phased population-based strategy for global acute myocardial infarction development is proposed.
  • A pharmacoinvasive approach to STEMI care is suggested, considering socioeconomic characteristics.
  • Analysis of cultural, demographic, and fiscal dynamics in lower-income countries influencing guideline adherence.

Main Results:

  • Adherence to current North American and European STEMI guidelines is often unrealistic in poorer countries.
  • Socioeconomic factors significantly impact the feasibility of implementing advanced STEMI interventions globally.
  • A pharmacoinvasive strategy offers a potential solution for improving STEMI outcomes in resource-limited settings.

Conclusions:

  • Global STEMI care requires strategies adapted to local socioeconomic realities.
  • A pharmacoinvasive approach, based on socioeconomic stratification, is a viable alternative for acute myocardial infarction management.
  • Tailored, population-based strategies are essential for advancing global STEMI intervention.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
567
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
419
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
366